News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zhejiang Wolwo Bio-Pharma Gains 94% Post-IPO



1/27/2014 10:56:35 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

January 24, 2014 -- Zhejiang Wolwo Bio-Pharmaceutical completed a very successful IPO this week, a 506 million RMB ($83.7 million) transaction that listed the company on the Shenzhen exchange. It was one of eight China companies to become publicly owned after China shut down the IPO process for 14 months. Regulators revamped the country’s IPO process to make it more market oriented. Wolwo finished the week with a strong 94% gain. After pricing at 20.05 RMB, it climbed to 38.81 RMB. More details....

Stock Symbol: (SHE: 300357)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES